Which factors contribute to the limitations of a study's results when communicating with a patient considering a treatment based on its findings?

• A. All of the above
• B. Sample size limits
• C. Generalizability to other populations
• D. Biases in study design

Answer: (A)

The key idea is that several study limitations shape how confidently you can apply findings to a real patient. When a patient is weighing a treatment based on research, you need to convey not just the results but also how solid those results are.

First, sample size matters because smaller studies tend to produce less precise estimates. With fewer participants, the observed effect can be more variable, and the true benefit or risk may be uncertain. This means you should communicate that the magnitude of benefit and the likelihood of side effects are less certain, especially for individuals who resemble the patient less closely.

Second, generalizability (whether the results apply to other populations) is crucial. If the study participants differ from the patient in important ways—age, underlying health, severity of illness, or setting—the findings may not hold for them. This limits how confidently you can recommend the treatment to this patient based on that study.

Third, biases in study design can distort results. Flaws like how participants were selected, how outcomes were measured, or how confounding factors were controlled can skew conclusions. Recognizing these biases helps you frame the findings with appropriate caution rather than presenting them as definitive for every patient.

Because all of these factors collectively limit how applicable and trustworthy the study results are for an individual patient, considering them together provides the most accurate context for communicating treatment decisions.